Investigational retinal camera measures oxygen saturation in the eye
Click Here to Manage Email Alerts
NEW ORLEANS — An investigational device that measures ocular oxygen saturation may help detect disease earlier and potentially preserve sight, according to a presenter at the Academy ’23 Innovations in Vision and Eye Care program.
Zilia CEO and co-founder Patrick Sauvageau, OD, MSc, told attendees that Zilia Ocular enables the measurement of oxygen saturation in the eye.
“Zilia is a medical technology company developing a breakthrough platform that combines imaging, spectroscopy and artificial intelligence to assess biomarkers in the eye,” he said. “There is a huge unmet need for early detection. Existing tools are used to assess irreversible damage to the eye. It’s clear we need to have [earlier] interventions to preserve sight.”
Damage to the eye is preceded by dysregulation of metabolic function, Sauvageau added, which can be assessed through ocular oximetry.
“Oxygen is crucial to proper function of the human retina,” he said, “but it is associated with conditions like glaucoma, age-related macular degeneration and diabetic retinopathy. Leveraging ocular oximetry provides actionable insights that empower timely intervention with existing treatment modalities.”
Sauvageau explained that with Zilia Ocular, low-intensity light travels through the eye and reflects off the fundus to be analyzed. The company is currently conducting research with a number of institutions and has enrolled 700 patients in clinical studies.
“Zilia’s technology can be used to assess a vast array of biomarkers in the eye, paving the way for other applications in neurology and cardiology,” he said.
Sauvageau noted that Zilia Ocular is an investigational device not yet available for sale in the U.S.
Collapse
Press Conference
Read more about
Click Here to Manage Email Alerts